Back to Authors

Bringhen, Sara

Mayo Clinic

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Citations 1

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

New England Journal of Medicine | December 9, 2024 | Volume: 392 | Issue: 18 | Pages: 1777-1788

10.1056/nejmoa2409029 | PMID 39652675